Increlex - supply shortage

Resolved
mecasermin
Shortage Human

Shortage information

The shortage affecting Increlex has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

Medicines affected
Increlex
Supply shortage status
Resolved
International non-proprietary name (INN) or common name
mecasermin
Therapeutic area (MESH)
Laron Syndrome
Pharmaceutical forms affected
Solution for subcutaneous injection
Strengths affected
10 mg/ml
Availability of alternatives
No

Key dates

First published

Share this page